KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rigel Pharmaceuticals (RIGL) Other financing activities (2018 - 2025)

Rigel Pharmaceuticals has reported Other financing activities over the past 8 years, most recently at $4.3 million for Q3 2025.

  • For Q3 2025, Other financing activities rose 2603.16% year-over-year to $4.3 million; the TTM value through Sep 2025 reached $6.6 million, up 573.91%, while the annual FY2024 figure was $2.0 million, 87.23% up from the prior year.
  • Other financing activities for Q3 2025 was $4.3 million at Rigel Pharmaceuticals, up from $418000.0 in the prior quarter.
  • Over five years, Other financing activities peaked at $4.3 million in Q3 2025 and troughed at $1000.0 in Q1 2023.
  • A 5-year average of $852941.2 and a median of $486000.0 in 2023 define the central range for Other financing activities.
  • Biggest five-year swings in Other financing activities: crashed 99.89% in 2023 and later skyrocketed 8800.0% in 2024.
  • Year by year, Other financing activities stood at $1.1 million in 2021, then crashed by 44.79% to $599000.0 in 2022, then decreased by 18.86% to $486000.0 in 2023, then skyrocketed by 201.44% to $1.5 million in 2024, then skyrocketed by 191.54% to $4.3 million in 2025.
  • Business Quant data shows Other financing activities for RIGL at $4.3 million in Q3 2025, $418000.0 in Q2 2025, and $484000.0 in Q1 2025.